Collaboration is at the heart of our research efforts in metabolomics, proteomics, and biomarker discovery. We actively engage with academic institutions, healthcare organizations, and industry partners to advance precision medicine and deepen our understanding of disease mechanisms. Through state-of-the-art mass spectrometry and multi-omics approaches, we strive to identify novel biomarkers for early disease detection, prognosis, and therapeutic targeting. Our partnerships foster innovation, enabling the translation of cutting-edge research into clinically relevant applications.
By fostering these strategic collaborations, we are able to address complex biomedical questions, strengthen our research infrastructure, and ensure that our work has both local and global impact. These partnerships allow